Atrial Fibrillation
Conditions
Keywords
atrial arrhythmia, atrial fibrillation, stroke, bleeding, Left Atrial Appendage Occlusion
Brief summary
The purpose of this research is to learn more about the normal care of patients with a new or pre-existing diagnosis of atrial fibrillation (AF). These abnormal and irregular heartbeats place patients at increased risk of developing clots in their bloodstream that could potentially lead to stroke. Normal care is designed to help prevent this from happening and to lessen or eliminate the symptoms patients may have. There are many different types of AF as well as numerous ways in which a variety of patients are treated. The investigators are interested in gathering more information to better keep track of patient treatment patterns (trends) that may differ from physician to physician, hospital to hospital, medication to medication, patient to patient and if necessary, procedure to procedure.
Detailed description
The objective of this research is to establish a contemporary and simple to construct AF management registry that expands progressively over the continuum of care for each individual patient. The registry will be used to determine the course and progression of AF management in preventing thrombo-embolic events using rhythm and rate control interventions. Primary endpoints: 1. Atrial fibrillation natural history 2. Thrombo-embolic event 3. Death Secondary endpoints: 1. Bleeding 2. Pro-arrhythmia 3. Patient adherence 4. Treatment complication
Interventions
None listed
Sponsors
CorVita Science Foundation
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Diagnosis of valvular or non valvular atrial fibrillation 2. ECG documented atrial fibrillation A. 12 lead B. Rhythm strip C. Event monitor D. Holter Monitor E. Implantable loop recorder
Exclusion criteria
1. Age below 18 years. 2. Clinical evidence that death within 6 months is possible 3. Inability to consent to the research or sign a consent form 4. Inability to follow up at the research clinic at least annually for continuity of AF care and management
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Recurrence of Atrial fibrillation | From enrollment to 10- year study completion | The natural progression of the condition will be assessed per medical record review |
| Number of participants who had thrombo-embolic event | From enrollment to 10- year study completion | All strokes, transient ischemic and systemic thrombo-embolic events |
| Mortality | From enrollment to 10- year study completion | All cause death will be noted |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants who have experienced bleeding | From enrollment to 10- year study completion | All bleeding events events will be will be assessed throughout the duration of the study per medical record review |
| Treatment complication | From enrollment to 10- year study completion | All adverse outcomes/events related to routine standard of care treatments will be noted and assessed for the duration of the study per medical record review |
| Number of patients who have had pro-arrhythmia events | From enrollment to 10- year study completion | All pro-arrhythmic events will be documented and assessed |
| Number of patients who have had patient adherence events | From enrollment to 10- year study completion | Events relating to subject non-compliance of medications will be documented for the duration of the study per medical record review |
Countries
United States
Contacts
Primary ContactEdward M Burke
Backup ContactMartin C Burke, DO
Outcome results
None listed